"Anti-Retroviral Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents used to treat RETROVIRIDAE INFECTIONS.
| Descriptor ID |
D044966
|
| MeSH Number(s) |
D27.505.954.122.388.077
|
| Concept/Terms |
Anti-Retroviral Agents- Anti-Retroviral Agents
- Agents, Anti-Retroviral
- Anti Retroviral Agents
- Antiretroviral Agents
- Agents, Antiretroviral
|
Below are MeSH descriptors whose meaning is more general than "Anti-Retroviral Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Retroviral Agents".
This graph shows the total number of publications written about "Anti-Retroviral Agents" by people in this website by year, and whether "Anti-Retroviral Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2009 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 4 | 1 | 5 |
| 2013 | 2 | 0 | 2 |
| 2014 | 4 | 2 | 6 |
| 2015 | 2 | 2 | 4 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 5 | 1 | 6 |
| 2019 | 1 | 1 | 2 |
| 2020 | 1 | 1 | 2 |
| 2021 | 2 | 3 | 5 |
| 2022 | 0 | 4 | 4 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Retroviral Agents" by people in Profiles.
-
Common antiretroviral combinations are associated with somatic depressive symptoms in women with HIV. AIDS. 2024 Feb 01; 38(2):167-176.
-
Long-Acting Formulations for the Prevention and Treatment of Human Immunodeficiency Virus (HIV)-1 Infection: Strategic Leveraging and Integration of Multidisciplinary Knowledge to Advance Public Health. Clin Infect Dis. 2022 Nov 21; 75(Supplement_4):S498-S501.
-
Obesity in HIV infection: host-pathogen interaction. AIDS. 2022 09 01; 36(11):1477-1491.
-
Bone Quality in Relation to HIV and Antiretroviral Drugs. Curr HIV/AIDS Rep. 2022 10; 19(5):312-327.
-
Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies. Clin Infect Dis. 2022 03 09; 74(5):865-870.
-
Class-Based Antiretroviral Exposure and Cognition Among Women Living with HIV. AIDS Res Hum Retroviruses. 2022 07; 38(7):561-570.
-
Positive Psychological Factors and Life Themes in Relation to Health Outcomes in Women Living with HIV. Int J Behav Med. 2022 Aug; 29(4):469-479.
-
Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV. Nat Commun. 2021 06 29; 12(1):3922.
-
Pharmacokinetics and safety of maraviroc in neonates. AIDS. 2021 03 01; 35(3):419-427.
-
Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption. mBio. 2021 02 23; 12(1).